Questions from the collection
Questions about NAD+
Some questions have a useful study attached. Others have a plausible story and a conspicuous absence of human results.
Is taking NAD orally effective?
The clearest human result concerns the precursors NR and NMN: NR raised whole-blood NAD+ in a controlled trial and NMN did so in middle-aged adults. A capsule’s actual ingredient matters. The skin-cell experiment showed extracellular processing of NAD in cultured cells; it cannot establish the effectiveness of a swallowed NAD+ capsule. I don’t give the front label the last word.
Does NAD affect body weight?
In the NMN trial in prediabetic, postmenopausal women, muscle insulin sensitivity improved while body composition stayed unchanged. These papers establish no weight-loss treatment and no lasting answer about weight gain. I credit the muscle finding, with the unchanged body composition beside it.
Does NAD make you look younger?
Mouse experiments and cellular work give reasons to study NAD+ in ageing. The 2025 human evidence review describes limited efficacy. No human trial in this reading list shows reversal of visible ageing with NAD+ or these precursors. The biological-age measure in the middle-aged NMN trial did not increase; that result cannot supply a claim about younger-looking skin.
Is daily NAD+ use safe?
Short NR trials reported tolerability at the amounts studied, and NR-SAFE reported no moderate or severe adverse events over 30 days. Those observations cover the populations and durations examined. Safety over much longer use remains an open question.
IV use introduces infusion symptoms and compounding risks, described in the IV record. Cancer is a further context-dependent concern because NAD+ also supports existing tumor metabolism. The cellular review explains why a molecule can have several biological roles; personal risk needs a clinician who knows the case.
Do NAD patches work?
The controlled human evidence here is concentrated in oral NR and oral NMN. The reading list supplies no randomized demonstration that NAD+ patches raise NAD+. The same gap applies to the marketed nasal, skin and under-the-tongue routes discussed in the research record. I’d reserve judgment until the actual delivery route has a controlled human test.
Morning and evening use
NAMPT, an enzyme involved in rebuilding NAD+, follows a circadian rhythm. That is an interesting biological reason to investigate timing. The human studies here establish no preferred morning or evening schedule. A clock mechanism alone cannot pick an hour.
How long do side effects last?
IV reports describe symptoms easing when infusions were slowed or stopped, with little precise duration information. The oral safety trials measured a different route and chemical. An infusion anecdote offers little guidance about an NR capsule, or the reverse. The study-amount record puts the oral tolerability observations beside their durations.